Post by
DrJayser on Feb 01, 2021 10:37am
28,000$ SALES IN A YEAR exemplary succes-WOW-
"We are very excited to bring our first nutraceutical designed and developed to promote advanced immune support for humans to market through our strong partnership with Mimi's Rock," says Kym Anthony, Chief Executive Officer, Avivagen, Inc. "There has already been exemplary success and uptake for OxC-betaTM applications for companion animal and livestock uses, including a high-quality supplement for companion animals launched with Mimi's Rock last year. We believe Dr. Tobias Beta Blend will be well received by consumers looking to improve their immune system health."
Comment by
Justreality on Feb 06, 2021 10:12pm
Why the big hate on for VIV? Lost money on stock is my guess but just wondering. I dont know the story that well just a buddy broker told me to buy it so thought would check it out. Thanks for any insights.